The Society for Immunotherapy of Cancer (SITC) hosted the Autoimmunity and Immuno-Oncology Virtual Summit on Wednesday, March 18, 2026, from 1–4 p.m. ET. This open-door virtual event highlighted the emerging role of immunotherapies in treating autoimmune diseases. Expert faculty presenters provided an overview of autoimmunity, the current state of knowledge of immunotherapies for autoimmune diseases, mechanisms of toxicities and their management in different patient populations, and areas of opportunity at the intersection of immuno-oncology (IO) and rheumatology.
More information about the program, including the webinar agenda, can be found here.
The 2026 SITC Autoimmunity and Immuno-Oncology Virtual Summit is supported, in part, by: Genentech, a member of the Roche Group, and an anonymous donor. (Supporters as of March 17, 2026)
Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Date: March 18, 202600:24:03
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Speaker: Andreas Mackensen, MD; Date: March 18, 202600:25:01
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Speaker: Erin Wilfong, MD, PhD; Date: March 18, 202600:28:07
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Date: March 18, 202600:20:00
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Speaker: Nasheed M. Hossain, MD; Date: March 18, 202600:25:07
Meeting: Autoimmunity and Immuno-Oncology Virtual Summit; Speaker: Maximilian Konig, MD; Date: March 18, 202600:26:55